IDXX Stock Set to Benefit From IDEXX Cancer Dx Diagnostic Panel Launch

IDEXX Laboratories, Inc. (IDXX) has unveiled the IDEXX Cancer Dx, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs. This affordable and accessible blood test can be added to panels for sick pets and integrated into annual wellness screenings for as low as $15, providing veterinarians in the United States with actionable results within two to three days.The test is especially crucial for the 20 million dogs in North America who face an increased risk of cancer. Early detection an ...